In contrast to CD3+CD56+ T cells, we did not detect differences between ALS patients and HVs in HLA-DR expression on monocytes, percentage of HLA-DRlo/neg monocytes, or cell counts (Fig 6A and S1 Table). This evidence concerns the gene NCAM1 and amyotrophic lateral sclerosis.